Koistinen et al., 1989 - Google Patents
Common binding region of complement factors B, H and CR1 on C3b revealed by monoclonal anti-C3dKoistinen et al., 1989
- Document ID
- 9504744736480051938
- Author
- Koistinen V
- Wessberg S
- Leikola J
- Publication year
- Publication venue
- Complement and inflammation
External Links
Snippet
Fab fragments of a murine C3d-specific monoclonal antibody, clone 4C2, strongly inhibited the binding of H, and up to about 80% that of B, to C3b on sheep erythrocytes, as shown by using radiolabelled purified proteins. The inhibition was also detected in the fluid phase …
- 230000000295 complement 0 title description 4
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
- C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Koistinen et al. | Common binding region of complement factors B, H and CR1 on C3b revealed by monoclonal anti-C3d | |
EP0182634B1 (en) | Diagnostic methods employing antibodies | |
Morrissey et al. | Monoclonal antibody analysis of purified and cell-associated tissue factor | |
Du et al. | Glycoprotein Ib and glycoprotein IX are fully complexed in the intact platelet membrane | |
Lachmann et al. | Breakdown of C3 after complement activation. Identification of a new fragment C3g, using monoclonal antibodies. | |
Mollnes et al. | Monoclonal antibodies recognizing a neoantigen of poly (C9) detect the human terminal complement complex in tissue and plasma | |
Fujita et al. | The mechanism of action of decay-accelerating factor (DAF). DAF inhibits the assembly of C3 convertases by dissociating C2a and Bb. | |
Reed et al. | Platelet factor XIII increases the fibrinolytic resistance of platelet-rich clots by accelerating the crosslinking of α2-antiplasmin to fibrin | |
Berggård et al. | Prothrombin, albumin and immunoglobulin A form covalent complexes with α1‐microglobulin in human plasma | |
Ghebrehiwet et al. | Identification of the Raji cell membrane-derived C1q inhibitor as a receptor for human C1q. Purification and immunochemical characterization. | |
US4657894A (en) | New factor VIII coagulant polypeptides | |
Tedesco et al. | Two types of dysfunctional eighth component of complement (C8) molecules in C8 deficiency in man. Reconstitution of normal C8 from the mixture of two abnormal C8 molecules. | |
CA1341506C (en) | Factor viii coagulant polypeptides and monoclonal antibodies to them | |
US4886876A (en) | Factor VIII coagulant polypeptides | |
Ploplis et al. | Monoclonal antibodies to discrete regions of human Glu1-plasminogen | |
Choi et al. | Purification of a Streptococcus mutans protein that binds to heart tissue and glycosaminoglycans | |
Burge et al. | Isolation of C4-binding protein from guinea pig plasma and demonstration of its function as a control protein of the classical complement pathway C3 convertase. | |
US5773228A (en) | Activation-dependent protein expressed on the surface of activated platelets and antibodies thereto | |
US4857635A (en) | Factor VIII coagulant polypeptides and monoclonal antibodies tof them | |
Foster et al. | Monoclonal antibodies selective for the functional states of bovine factor V and factor Va | |
Levine et al. | Platelet factor 4 and the platelet secreted proteoglycan: immunologic characterization by crossed immunoelectrophoresis | |
Kosaka et al. | Hyperviscosity syndrome associated with an idiopathic monoclonal IgA-rheumatoid factor | |
Lebrazi et al. | Human anti-streptokinase antibodies induce platelet aggregation in an Fc receptor (CD32) dependent manner | |
US5446132A (en) | Thrombin-activated platelet protein-2 (TAPP-2) | |
KR930002834B1 (en) | Anti-urokinase monoclonal antibody bearing matrix capable of separating and puritying workinase from biological sources |